210 related articles for article (PubMed ID: 20206716)
1. Genetic variation within the gene encoding the HIV-1 CCR5 coreceptor in two South African populations.
Picton AC; Paximadis M; Tiemessen CT
Infect Genet Evol; 2010 May; 10(4):487-94. PubMed ID: 20206716
[TBL] [Abstract][Full Text] [Related]
2. CCR5 promoter haplotypes differentially influence CCR5 expression on natural killer and T cell subsets in ethnically divergent HIV-1 uninfected South African populations.
Picton AC; Paximadis M; Tiemessen CT
Immunogenetics; 2012 Nov; 64(11):795-806. PubMed ID: 22893032
[TBL] [Abstract][Full Text] [Related]
3. Mutations in C-C chemokine receptor type 5 (CCR5) in South African individuals.
Barmania F; Potgieter M; Pepper MS
Int J Infect Dis; 2013 Dec; 17(12):e1148-53. PubMed ID: 23911155
[TBL] [Abstract][Full Text] [Related]
4. Cis-regulatory genetic variants in the CCR5 gene and natural HIV-1 control in black South Africans.
Koor GW; Paximadis M; Picton ACP; Karatas F; Loubser SA; He W; Ahuja SK; Chaisson RE; Martinson N; Ebrahim O; Tiemessen CT
Clin Immunol; 2019 Aug; 205():16-24. PubMed ID: 31100442
[TBL] [Abstract][Full Text] [Related]
5. Global survey of genetic variation in CCR5, RANTES, and MIP-1alpha: impact on the epidemiology of the HIV-1 pandemic.
Gonzalez E; Dhanda R; Bamshad M; Mummidi S; Geevarghese R; Catano G; Anderson SA; Walter EA; Stephan KT; Hammer MF; Mangano A; Sen L; Clark RA; Ahuja SS; Dolan MJ; Ahuja SK
Proc Natl Acad Sci U S A; 2001 Apr; 98(9):5199-204. PubMed ID: 11320252
[TBL] [Abstract][Full Text] [Related]
6. Association between HIV-1 tropism and CCR5 human haplotype E in a Caucasian population.
Huik K; Avi R; Uibopuu H; Pauskar M; Margus T; Karki T; Krispin T; Kool P; Rüütel K; Talu A; Abel-Ollo K; Uusküla A; Carrillo A; He W; Ahuja SK; Lutsar I
J Acquir Immune Defic Syndr; 2014 Jul; 66(3):239-44. PubMed ID: 24508837
[TBL] [Abstract][Full Text] [Related]
7. Race-specific HIV-1 disease-modifying effects associated with CCR5 haplotypes.
Gonzalez E; Bamshad M; Sato N; Mummidi S; Dhanda R; Catano G; Cabrera S; McBride M; Cao XH; Merrill G; O'Connell P; Bowden DW; Freedman BI; Anderson SA; Walter EA; Evans JS; Stephan KT; Clark RA; Tyagi S; Ahuja SS; Dolan MJ; Ahuja SK
Proc Natl Acad Sci U S A; 1999 Oct; 96(21):12004-9. PubMed ID: 10518566
[TBL] [Abstract][Full Text] [Related]
8. CCR2, CCR5, and CXCL12 variation and HIV/AIDS in Papua New Guinea.
Mehlotra RK; Hall NB; Bruse SE; John B; Zikursh MJB; Stein CM; Siba PM; Zimmerman PA
Infect Genet Evol; 2015 Dec; 36():165-173. PubMed ID: 26397046
[TBL] [Abstract][Full Text] [Related]
9. Influence of CCR5 promoter haplotypes on AIDS progression in African-Americans.
An P; Martin MP; Nelson GW; Carrington M; Smith MW; Gong K; Vlahov D; O'Brien SJ; Winkler CA
AIDS; 2000 Sep; 14(14):2117-22. PubMed ID: 11061652
[TBL] [Abstract][Full Text] [Related]
10. Association of chemokine receptor gene (CCR2-CCR5) haplotypes with acquisition and control of HIV-1 infection in Zambians.
Malhotra R; Hu L; Song W; Brill I; Mulenga J; Allen S; Hunter E; Shrestha S; Tang J; Kaslow RA
Retrovirology; 2011 Mar; 8():22. PubMed ID: 21429204
[TBL] [Abstract][Full Text] [Related]
11. Marked differences in CCR5 expression and activation levels in two South African populations.
Picton AC; Shalekoff S; Paximadis M; Tiemessen CT
Immunology; 2012 Aug; 136(4):397-407. PubMed ID: 22509959
[TBL] [Abstract][Full Text] [Related]
12. Distribution of human chemokine (C-X3-C) receptor 1 (CX3CR1) gene polymorphisms and haplotypes of the CC chemokine receptor 5 (CCR5) promoter in Chinese people, and the effects of CCR5 haplotypes on CCR5 expression.
Li C; Lu SC; Hsieh PS; Huang YH; Huang HI; Ying TH; Shieh B
Int J Immunogenet; 2005 Apr; 32(2):99-106. PubMed ID: 15787642
[TBL] [Abstract][Full Text] [Related]
13. CCR5 promoter haplotype transcription complex characterization.
Jiang D; Mummidi S; Ahuja SK; Jarrett HW
J Health Care Poor Underserved; 2011; 22(4 Suppl):73-90. PubMed ID: 22102307
[TBL] [Abstract][Full Text] [Related]
14. New genetic variants in the CCR5 gene and the distribution of known polymorphisms in Omani population.
Al-Mahruqi SH; Zadjali F; Koh CY; Balkhair A; Said EA; Al-Balushi MS; Hasson SS; Al-Jabri AA
Int J Immunogenet; 2014 Feb; 41(1):20-8. PubMed ID: 23953748
[TBL] [Abstract][Full Text] [Related]
15. [Identification of new mutant sites and 894C deletion variant genotyping of HIV-1 coreceptor CCR5 in indigenous Chinese populations].
Liu M; Wang F; Hong W; Wang B; Jin L; Lei Z; Hou J
Zhonghua Yi Xue Za Zhi; 2002 Nov; 82(21):1468-72. PubMed ID: 12509908
[TBL] [Abstract][Full Text] [Related]
16. Polymorphism of CCR5 affecting HIV disease progression in the Japanese population.
Kageyama S; Mimaya J; Yamada K; Kurimura T; Shiraki K;
AIDS Res Hum Retroviruses; 2001 Jul; 17(11):991-5. PubMed ID: 11485615
[TBL] [Abstract][Full Text] [Related]
17. Combined effect of CCR5-Delta32 heterozygosity and the CCR5 promoter polymorphism -2459 A/G on CCR5 expression and resistance to human immunodeficiency virus type 1 transmission.
Hladik F; Liu H; Speelmon E; Livingston-Rosanoff D; Wilson S; Sakchalathorn P; Hwangbo Y; Greene B; Zhu T; McElrath MJ
J Virol; 2005 Sep; 79(18):11677-84. PubMed ID: 16140745
[TBL] [Abstract][Full Text] [Related]
18. Interleukin-8 genetic diversity, haplotype structure and production differ in two ethnically distinct South African populations.
Paximadis M; Picton ACP; Sengupta D; Ramsay M; Puren A; Tiemessen CT
Cytokine; 2021 Jul; 143():155489. PubMed ID: 33814271
[TBL] [Abstract][Full Text] [Related]
19. Influence of CCR5 and CCR2 genetic variants in the resistance/susceptibility to HIV in serodiscordant couples from Colombia.
Zapata W; Aguilar-Jiménez W; Pineda-Trujillo N; Rojas W; Estrada H; Rugeles MT
AIDS Res Hum Retroviruses; 2013 Dec; 29(12):1594-603. PubMed ID: 24098976
[TBL] [Abstract][Full Text] [Related]
20. Effect of TNF-alpha genetic variants and CCR5 Delta 32 on the vulnerability to HIV-1 infection and disease progression in Caucasian Spaniards.
Veloso S; Olona M; García F; Domingo P; Alonso-Villaverde C; Broch M; Peraire J; Viladés C; Plana M; Pedrol E; López-Dupla M; Aguilar C; Gutiérrez M; Leon A; Tasias M; Gatell JM; Richart C; Vidal F
BMC Med Genet; 2010 Apr; 11():63. PubMed ID: 20420684
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
